Exploring Mechanisms and Morphology of QT Interval Prolongation
NCT03291145
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Long Qt Syndrome 1-2
Sudden Cardiac Death
Interventions
DRUG:
Beta Blockers
DRUG:
Spironolactone
Sponsor
Herlev and Gentofte Hospital